General MedicationsINJECTIONGeneric
PAMIDRONATE DISODIUM
PAMIDRONATE DISODIUM
Standard Dose
30MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview PAMIDRONATE DISODIUM is listed in Drugs@FDA under application 078300 (ANDA).
Marketing status: Discontinued Active ingredient PAMIDRONATE DISODIUM Form and strength INJECTABLE;INJECTION - 30MG/VIAL Sponsor MN PHARMS Submission history Latest submission status date: 2009-03-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview PAMIDRONATE DISODIUM is listed in Drugs@FDA under application 078300 (ANDA). Marketing status: Discontinued Active ingredient PAMIDRONATE DISODIUM Form and strength INJECTABLE;INJECTION - 30MG/VIAL Sponsor MN PHARMS Submission history Latest submission status date: 2009-03-10 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.